APA (7th ed.) Citation

F, G., B, J., J, J., Z, H., T, T., T, T., . . . L, J. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science advances, 11(17), eadu0847. https://doi.org/10.1126/sciadv.adu0847

Chicago Style (17th ed.) Citation

F, Gui, et al. "Acute BRCAness Induction and AR Pathway Blockage Through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer." Science Advances 11, no. 17 (2025): eadu0847. https://doi.org/10.1126/sciadv.adu0847.

MLA (9th ed.) Citation

F, Gui, et al. "Acute BRCAness Induction and AR Pathway Blockage Through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer." Science Advances, vol. 11, no. 17, 2025, p. eadu0847, https://doi.org/10.1126/sciadv.adu0847.